1. Home
  2. CMRE vs AGIO Comparison

CMRE vs AGIO Comparison

Compare CMRE & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Costamare Inc. $0.0001 par value

CMRE

Costamare Inc. $0.0001 par value

HOLD

Current Price

$16.04

Market Cap

1.8B

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$27.80

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMRE
AGIO
Founded
1974
2007
Country
Monaco
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
CMRE
AGIO
Price
$16.04
$27.80
Analyst Decision
Hold
Buy
Analyst Count
1
8
Target Price
$12.00
$37.63
AVG Volume (30 Days)
437.9K
708.3K
Earning Date
01-01-0001
05-15-2026
Dividend Yield
2.84%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$43,011,000.00
Revenue This Year
N/A
$75.68
Revenue Next Year
N/A
$167.63
P/E Ratio
$5.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.63
$22.24
52 Week High
$17.91
$46.00

Technical Indicators

Market Signals
Indicator
CMRE
AGIO
Relative Strength Index (RSI) 40.66 46.37
Support Level $15.21 $26.48
Resistance Level $16.67 $29.49
Average True Range (ATR) 0.57 1.13
MACD -0.16 -0.17
Stochastic Oscillator 7.21 25.09

Price Performance

Historical Comparison
CMRE
AGIO

About CMRE Costamare Inc. $0.0001 par value

Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and among others. Costamare provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: